PATENT CLAIM ANALYSIS

Application Number: 15999708
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "401000"]

Abstract:
The present invention is directed to the treatment of skin erythema as exhibited in rosacea and other conditions characterized by increased erythema (redness) of the skin. These conditions exhibit dilation of blood vessels due to a cutaneous vascular hyper-reactivity. In particular, the present invention is directed to a novel composition and method for the treatment of skin erythema using α 1 -adrenergic receptor (α 1 -adrenoceptor) agonists incorporated into cosmetic, pharmacological or dermatological compositions for topical application to the skin.

Claim (Index 29):
The method of  claim 25 , wherein the agent is administered in a therapeutically effective amount.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 96.0
- Lexical Diversity: 1.53448
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12901911', '12901755', '12788746', '10763807', '13309403']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8162754364314847
- 35 USC 102 Novelty (BERT): 0.5347274295548687
- Combined Prediction Score: 0.7881206357438231
- Mean Citation Score: 388.329602
- Max Citation Score: 425.81903
- Similarity Product: 203.2690272432101

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test